Patents by Inventor Timothy D. Holland

Timothy D. Holland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963691
    Abstract: A surgical instrument, has an end effector that includes an ultrasonic blade, and a clamp arm that moves relative to the ultrasonic blade from an opened position toward an intermediate position and a closed position. The clamp arm is offset from the ultrasonic blade to define a predetermined gap in the intermediate position between the opened position and the closed position. A clamp arm actuator connects to the clamp arm and moves from an opened configuration to a closed configuration to direct the clamp arm from the opened position toward the intermediate position and the closed position. A spacer connects with the clamp arm to inhibit movement of the clamp arm from the intermediate position toward the closed position for maintaining the predetermined gap between the clamp arm and the ultrasonic blade.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: April 23, 2024
    Assignee: Cilag GmbH International
    Inventors: Ryan M. Asher, Brian D. Black, John E. Brady, Joseph Dennis, Geni M. Giannotti, Bryce L. Heitman, Timothy S. Holland, Joseph E. Hollo, Andrew Kolpitcke, Amy M. Krumm, Jason R. Lesko, Matthew C. Miller, David A. Monroe, Ion V. Nicolaescu, Rafael J. Ruiz Ortiz, Matthew S. Schneider, Richard C. Smith, Shawn C. Snyder, Sarah A. Worthington, Monica L. Rivard, Fajian Zhang
  • Patent number: 11926877
    Abstract: A saliva-based testing method that bypasses the need for RNA isolation/purification is described herein. In experiments with inactivated SARS-CoV-2 virus spiked into saliva, this method has a limit of detection of 500-1000 viral particles per mL, rivalling the standard NP swab method. Initial studies showed excellent performance with 100 clinical samples. This saliva-based process is operationally simple, utilizes readily available materials, and can be easily implemented by existing testing sites thus allowing for high-throughput, rapid, and repeat testing of large populations.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: March 12, 2024
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Diana Rose Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang, Christopher B. Brooke, Martin D. Burke, Timothy M. Fan, Paul J. Hergenrother
  • Patent number: 6811550
    Abstract: Improved devices, systems, and methods for inhibiting hyperplasia in blood vessels provide controlled and safe cryotherapy treatment of a target portion within a body lumen of a patient. Efficacy of endoluminal cryogenic cooling can be enhanced by limiting cooling of target tissues using a thermal barrier disposed between a dual balloon cryotherapy catheter. Containment of both balloons can be monitored by applying a vacuum within a space between the first and second balloons, and by coupling the vacuum space to a fluid shutoff so as to inhibit flow of cryogenic fluid in response to a change in the vacuum space. Controlled cooling of the vessel can be improved by use of a nebulizer in fluid communication with a cryogenic liquid supply lumen and a gas supply lumen.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: November 2, 2004
    Assignee: CryoVascular Systems, Inc.
    Inventors: Timothy D. Holland, James Joye, Ronald Williams, Richard Williams
  • Patent number: 6514245
    Abstract: Improved devices, systems, and methods for inhibiting hyperplasia in blood vessels provide controlled and safe cryotherapy treatment of a target portion within a body lumen of a patient. Efficacy of endoluminal cryogenic cooling can be enhanced by limiting cooling of target tissues using a thermal barrier disposed between a dual balloon cryotherapy catheter. Containment of both balloons can be monitored by applying a vacuum within a space between the first and second balloons, and by coupling the vacuum space to a fluid shutoff so as to inhibit flow of cryogenic fluid in response to a change in the vacuum space. Controlled cooling of the vessel can be improved by use of a nebulizer in fluid communication with a cryogenic liquid supply lumen and a gas supply lumen.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: February 4, 2003
    Assignee: Cryovascular Systems, Inc.
    Inventors: Ronald Williams, James Joye, Richard S. Williams, Timothy D. Holland
  • Publication number: 20020183731
    Abstract: Improved devices, systems, and methods for inhibiting hyperplasia in blood vessels provide controlled and safe cryotherapy treatment of a target portion within a body lumen of a patient. Efficacy of endoluminal cryogenic cooling can be enhanced by limiting cooling of target tissues using a thermal barrier disposed between a dual balloon cryotherapy catheter. Containment of both balloons can be monitored by applying a vacuum within a space between the first and second balloons, and by coupling the vacuum space to a fluid shutoff so as to inhibit flow of cryogenic fluid in response to a change in the vacuum space. Controlled cooling of the vessel can be improved by use of a nebulizer in fluid communication with a cryogenic liquid supply lumen and a gas supply lumen.
    Type: Application
    Filed: July 11, 2002
    Publication date: December 5, 2002
    Applicant: CRYOVASCULAR SYSTEMS, INC., A Delaware Corporation
    Inventors: Timothy D. Holland, James Joye, Ronald Williams, Richard S. Williams
  • Patent number: D746448
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: December 29, 2015
    Assignee: C2 Therapeutics, Inc.
    Inventors: Patrick P. Wu, Timothy D. Holland, Gabriel Francis Wilgus Newell